In addition, patients with high Gal-9 expression had significantly higher survival than those with low Gal-9 expression, and similar results were seen in studies of melanoma, cervical squamous cell carcinoma, and hepatocellular carcinoma. The gene discussed is LGALS9; the disease is hepatocellular carcinoma.